STOCK TITAN

Zimmer Biomet Announces New Chief Medical Advisors to Help Improve Standard of Musculoskeletal Care

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)

Zimmer Biomet (NYSE:ZBH) has strengthened its medical leadership with two key appointments. Dr. Jonathan M. Vigdorchik joins as Chief Medical Technology Advisor for Adult Reconstruction and Hip Implants, while Dr. Anand M. Murthi becomes Chief Medical Advisor for Shoulder, Sports, Extremities, and Trauma (S.E.T.).

Both advisors will contribute their clinical expertise to guide product development, enhance medical education initiatives, and serve as strategic liaisons between Zimmer Biomet and the surgical community. Dr. Vigdorchik is from Hospital for Special Surgery in New York City, and Dr. Murthi serves at MedStar Union Memorial Hospital in Baltimore.

Zimmer Biomet (NYSE:ZBH) ha rafforzato la sua leadership medica con due nomine chiave. Il Dr. Jonathan M. Vigdorchik è stato nominato Chief Medical Technology Advisor per la Ricostruzione degli Adulti e gli Impianti d'Anca, mentre il Dr. Anand M. Murthi assume il ruolo di Chief Medical Advisor per Spalla, Sport, Arti e Traumi (S.E.T.).

Entrambi i consulenti apporteranno la loro esperienza clinica per orientare lo sviluppo dei prodotti, potenziare le iniziative di formazione medica e fungere da collegamento strategico tra Zimmer Biomet e la comunità chirurgica. Il Dr. Vigdorchik proviene dall'Hospital for Special Surgery di New York, e il Dr. Murthi presta servizio al MedStar Union Memorial Hospital di Baltimora.

Zimmer Biomet (NYSE:ZBH) ha reforzado su liderazgo médico con dos nombramientos clave. El Dr. Jonathan M. Vigdorchik se incorpora como Chief Medical Technology Advisor para Recontrucción de Adultos e Implantes de Cadera, mientras que el Dr. Anand M. Murthi asume el cargo de Chief Medical Advisor para Hombro, Deporte, Extremidades y Trauma (S.E.T.).

Ambos asesores aportarán su experiencia clínica para orientar el desarrollo de productos, mejorar las iniciativas de educación médica y actuar como enlaces estratégicos entre Zimmer Biomet y la comunidad quirúrgica. El Dr. Vigdorchik procede del Hospital for Special Surgery de Nueva York, y el Dr. Murthi trabaja en el MedStar Union Memorial Hospital de Baltimore.

Zimmer Biomet (NYSE:ZBH)는 두 명의 핵심 인사 영입으로 의료 리더십을 강화했습니다. Jonathan M. Vigdorchik 박사는 성인 재건 및 고관절 임플란트 담당 수석 의료기술 고문으로, Anand M. Murthi 박사는 어깨·스포츠·사지·외상(S.E.T.) 담당 수석 의료 고문으로 합류합니다.

두 고문 모두 제품 개발을 이끌고 의료 교육 프로그램을 강화하며 Zimmer Biomet과 외과 커뮤니티 간의 전략적 연결 역할을 수행하기 위해 임상 전문 지식을 제공할 예정입니다. Vigdorchik 박사는 뉴욕의 Hospital for Special Surgery 출신이며, Murthi 박사는 볼티모어의 MedStar Union Memorial Hospital에서 근무하고 있습니다.

Zimmer Biomet (NYSE:ZBH) a renforcé sa direction médicale avec deux nominations clés. Le Dr Jonathan M. Vigdorchik rejoint l'entreprise en tant que Chief Medical Technology Advisor pour la reconstruction adulte et les implants de hanche, tandis que le Dr Anand M. Murthi devient Chief Medical Advisor pour l'épaule, le sport, les extrémités et les traumatismes (S.E.T.).

Les deux conseillers apporteront leur expertise clinique pour orienter le développement des produits, renforcer les initiatives de formation médicale et servir d'interlocuteurs stratégiques entre Zimmer Biomet et la communauté chirurgicale. Le Dr Vigdorchik vient du Hospital for Special Surgery de New York, et le Dr Murthi exerce au MedStar Union Memorial Hospital de Baltimore.

Zimmer Biomet (NYSE:ZBH) hat seine medizinische Führung mit zwei wichtigen Ernennungen gestärkt. Dr. Jonathan M. Vigdorchik tritt als Chief Medical Technology Advisor für Erwachsenenrekonstruktion und Hüftimplantate bei, während Dr. Anand M. Murthi die Position des Chief Medical Advisor für Schulter, Sport, Extremitäten und Trauma (S.E.T.) übernimmt.

Beide Berater werden ihre klinische Expertise einbringen, um die Produktentwicklung zu lenken, medizinische Ausbildungsprogramme zu verbessern und als strategische Schnittstelle zwischen Zimmer Biomet und der chirurgischen Fachwelt zu fungieren. Dr. Vigdorchik kommt vom Hospital for Special Surgery in New York, Dr. Murthi arbeitet am MedStar Union Memorial Hospital in Baltimore.

Positive
  • None.
Negative
  • None.

Dr. Jonathan M. Vigdorchik Named Chief Medical Technology Advisor, Adult Reconstruction and Hip Implants

Dr. Anand M. Murthi Appointed Chief Medical Advisor, Shoulder, Sports, Extremities, and Trauma (S.E.T.)

WARSAW, Ind., Aug. 28, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointments of Jonathan M. Vigdorchik, MD, as Chief Medical Technology Advisor focused on Adult Reconstruction and Hip Implants, and Anand M. Murthi, MD, FAAOS, as Chief Medical Advisor, Shoulder, Sports, Extremities, and Trauma (S.E.T.). As strategic advisors, Drs. Vigdorchik and Murthi will leverage their extensive clinical experience to help guide the Company's new product pipeline and portfolio strategy across their respective areas of focus, and enhance Zimmer Biomet's medical education initiatives.

Dr. Vigdorchik is a board-certified, fellowship-trained orthopaedic surgeon at Hospital for Special Surgery (HSS) in New York City, specializing in hip and knee replacement surgery. Dr. Murthi is a board-certified, fellowship-trained orthopaedic surgeon who serves as Chief of Shoulder and Elbow Surgery and Director of the Shoulder and Elbow Fellowship Program at MedStar Union Memorial Hospital in Baltimore, Md.

"These appointments reflect Zimmer Biomet's commitment to deepening clinical collaboration and accelerating advancements across our portfolio – from implants and robotic technology to sports medicine and extremities," said Ivan Tornos, Chairman, President and Chief Executive Officer, Zimmer Biomet. "We're proud to welcome them both as strategic partners in helping to redefine the future of musculoskeletal care."

In these roles, Drs. Vigdorchik and Murthi will assist with our medical education and surgeon engagement; advise on the Company's technology and implant strategy and development roadmap; and serve as strategic liaisons between Zimmer Biomet and the broader surgical community.

About Dr. Jonathan M. Vigdorchik 
Dr. Vigdorchik holds several prominent academic and clinical leadership positions, including serving as Division Chief of Adult Reconstruction and Joint Replacement at HSS and Director of Bone Implant Longevity Research at HSS's Griffin Research Accelerator. In addition, he is currently an Associate Professor of Orthopaedic Surgery at Weill Cornell Medical College. He is active in professional societies including The Hip Society, The Knee Society, the American Academy of Orthopaedic Surgeons (AAOS) and the American Association of Hip and Knee Surgeons (AAHKS), where he currently serves as the Education and Communications Council Chair and earlier served as Program Chair for the 2024 AAHKS Annual Meeting.

Dr. Vigdorchik earned his medical degree from the University of Missouri – Columbia School of Medicine, completed his orthopaedic surgery residency at the Detroit Medical Center / Providence Hospital, and received fellowship training in Adult Reconstruction and Joint Replacement at HSS. He also completed an international traveling fellowship in hip preservation surgery with training at centers in Switzerland, Boston Children's Hospital, and Washington University in St. Louis.

Tornos said, "Dr. Vigdorchik is one of the most well-known, well-respected and well-published voices in orthopedics today. As a leading surgeon, clinical educator and true innovator, he brings an invaluable combination of experience and insight to this role. We are excited to partner with him as we continue to accelerate advancements in AI, smart implants, robotics and digital technologies that are redefining joint replacement care."

"I'm honored to take on this role with Zimmer Biomet at such an exciting time in the evolution of orthopedic care," said Dr. Vigdorchik. "We're at the intersection of AI, powerful digital technologies and advanced implants that together have the potential to dramatically improve outcomes and personalize care for each patient. I look forward to partnering with the Zimmer Biomet team to help shape the future of joint replacement."

About Dr. Anand M. Murthi
In addition to his role at MedStar, Dr. Murthi is also a Professor of Orthopaedic Surgery at Georgetown University School of Medicine. He is globally recognized for his expertise as an active surgeon, innovator, and pioneer in surgical techniques and device design. He is a founding member of prestigious societies including the Association of Clinical Elbow and Shoulder Surgeons (ACESS), Indian American Shoulder & Elbow Surgeons (IASES), and an active member of American Shoulder and Elbow Surgeons (ASES), where he established the Mentorship Program, chaired the Educational Committee, and was recently elected to the Neer Circle. He also serves as Co-Chairman of the Mid-Atlantic Shoulder and Elbow Society and the Orthopaedic Summit and Emerging Technologies Conference, while remaining a highly sought-after speaker and faculty member at major U.S. and international meetings. He is the Editor-in-Chief of Current Orthopaedic Practice Journal. He is also the co-designer of Shoulder JAM by OBERD, the first international shoulder data registry.

Dr. Murthi received his medical degree from Case Western Reserve University School of Medicine and completed his general surgery internship and orthopaedic surgery residency at George Washington University Medical Center. He completed a fellowship in shoulder and elbow reconstruction at the New York Orthopaedic Hospital – Columbia Presbyterian Medical Center. 

Tornos said, "Dr. Murthi brings deep clinical expertise, a proven track record of innovation, and visionary leadership in surgical techniques and device design. His partnership will be instrumental as we continue to accelerate growth across our S.E.T. business. With his influence and insight, Zimmer Biomet will further solidify our position as a trusted partner in delivering customer-centric solutions."

"Throughout my career, I've been driven by a passion for advancing surgical techniques and designing intelligent technologies that raise the standard of care in shoulder and elbow surgery," said Dr. Murthi. "I'm thrilled to join the Zimmer Biomet team—a team equally dedicated to innovation. Together, we have a remarkable opportunity to redefine what's possible in musculoskeletal care and deliver transformative solutions to surgeons and patients worldwide."

About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.

With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation. 

For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X / Twitter at www.x.com/zimmerbiomet.

Zimmer Biomet:


Media


Investors


Kristen Cardillo


David DeMartino


925-786-4913


646-531-6115


kristen.cardillo@zimmerbiomet.com


david.demartino@zimmerbiomet.com






Kirsten Fallon


Zach Weiner


781-779-5561


908-591-6955


kirsten.fallon@zimmerbiomet.com


zach.weiner@zimmerbiomet.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-announces-new-chief-medical-advisors-to-help-improve-standard-of-musculoskeletal-care-302539376.html

SOURCE Zimmer Biomet Holdings, Inc.

FAQ

Who are the new Chief Medical Advisors at Zimmer Biomet (ZBH)?

Dr. Jonathan M. Vigdorchik was appointed as Chief Medical Technology Advisor for Adult Reconstruction and Hip Implants, and Dr. Anand M. Murthi as Chief Medical Advisor for Shoulder, Sports, Extremities, and Trauma (S.E.T.).

What will be the role of the new medical advisors at Zimmer Biomet?

The advisors will guide the company's product pipeline, enhance medical education initiatives, advise on technology and implant strategy, and serve as strategic liaisons between Zimmer Biomet and the surgical community.

What are Dr. Vigdorchik's credentials at Zimmer Biomet?

Dr. Vigdorchik is a board-certified, fellowship-trained orthopaedic surgeon at Hospital for Special Surgery (HSS) in New York City, specializing in hip and knee replacement surgery.

What is Dr. Murthi's background at Zimmer Biomet?

Dr. Murthi is a board-certified, fellowship-trained orthopaedic surgeon who serves as Chief of Shoulder and Elbow Surgery and Director of the Shoulder and Elbow Fellowship Program at MedStar Union Memorial Hospital in Baltimore.
Zimmer Biomet

NYSE:ZBH

ZBH Rankings

ZBH Latest News

ZBH Latest SEC Filings

ZBH Stock Data

21.26B
197.78M
0.15%
98.94%
2.99%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
WARSAW